See Similar Listings

$12M Distributor of Medical Diagnostics Supplies to Labs & PoC

Los Angeles County, CA

Seller Financing Available

listing image
Gross Revenue:$12,398,000
Established Year:1986
EBITDA:$2,182,000
Listing ID: 2103374Listing provided by BizBuySell
BUSINESS DESCRIPTION

Integrated developer, marketer and distributor of laboratory and diagnostic instrumentation, reagents and consumables to labs and point of care.

Extensive product breadth means true vendor consolidation for customers:
Broad product suite across point of care (PoC) and lab applications with full-service distribution
Diversified client base across supplier, laboratory and healthcare organizations
Promotes laboratory efficiency and optimizes capabilities for customers
Reliable management information systems in place
Supply chain primarily U.S. based

Sustainable and growing revenue streams (34% CAGR over 5 years)
2022A Revenue of $12.4M, $2.2M Adj. EBITDA

As COVID revenue normalizes, the Company is currently in a transition year working on new product launches to fill the gap. TTM P&L as of April 2023:
- Revenue: $7.8M
- Adj. EBITDA: $500k

ATTACHED DOCUMENTS
GT Securities - Buyer NDA.docx.docx Download
DETAILED INFORMATION
Location
Los Angeles County, CA
Inventory
Not Included in asking price
Real Estate
Leased
Employees
10
Competition
$27.8B market opportunity rising at 6.2% CAGR. Increasing demand for advanced diagnostics and precision underpins market growth. Hospitals & laboratories have demonstrated a rising preference for PoC testing to get faster and accurate real time data. Introduction of rapid PCR testing with wide-spread applications is expected to propel the industry. Fragmented industry with a handful of large incumbents.
Growth & Expansion
New contracts and products in the pipeline to swell revenue. Competitive pricing and new product launches in the Core Lab and PoC segments in 2024-2025 to substantially expand footprint and enhance revenue. Projected sales could double upon an expected FDA clearance of a new pipeline product. Large upside opportunity via a proprietary plug-and-play platform that supports the infusion of new products into the ecosystem. Future growth strategy includes acquisitions.
Reason for Selling
Retiring active principal (50% owner)
Report an Issue with this listing
profile-img
Growthink
Capital
logo-img
Phone Number
Growthink Capital
Call Phone